Vaxcyte将Lonza位于Visp工厂的制造投资列为2024年关键支出——生物工艺国际报道
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure BioProcess International
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure BioProcess International